4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-134070
Chief Scientific Officer acquired 66,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Beskrovnaya Oxana Chief Scientific Officer | 2024-12-04 | Grant or award | +39,100 | 176,619 | D | ||
| Beskrovnaya Oxana Chief Scientific Officer | 2024-12-04 | Grant or award | +27,400 | 204,019 | D | ||
| Derivatives | |||||||
| Beskrovnaya Oxana Chief Scientific Officer | 2024-12-04 | Grant or award · Stock option (right to buy) | +62,400 | 62,400 | D | ||
Loading xslF345X05/ownership.xml…